Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.78 and traded as low as $0.72. Nemus Bioscience shares last traded at $0.7701, with a volume of 168,687 shares changing hands.
Nemus Bioscience Trading Up 7.9%
The stock has a market cap of $103.12 million, a PE ratio of -8.56 and a beta of -0.04. The firm’s fifty day moving average is $0.78.
About Nemus Bioscience
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Further Reading
- Five stocks we like better than Nemus Bioscience
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
